Petros Pharm Inc (PTPI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Operating Expenses | 989 | 1,027 | 392 | 991 | 1,801 |
| Operating Income | -989 | -1,027 | -392 | -991 | -1,801 |
| Other Income | 33 | 40 | 55 | 68 | -241 |
| Pre-tax Income | -956 | -987 | -337 | -923 | -2,041 |
| Net Income Continuous | -956 | -987 | -337 | -923 | -2,041 |
| Net Income Discontinuous | N/A | 0 | -7,474 | N/A | 14,948 |
| Net Income | $-956 | $-987 | $-337 | $-923 | $5,433 |
| EPS Basic Total Ops | -0.30 | -0.03 | 9.04 | -0.03 | -1.20 |
| EPS Basic Continuous Ops | -0.30 | -0.03 | 8.19 | -0.03 | -1.49 |
| EPS Basic Discontinuous Ops | N/A | N/A | 0.85 | N/A | 0.29 |
| EPS Diluted Total Ops | -0.30 | -0.03 | 9.04 | -0.03 | -1.20 |
| EPS Diluted Continuous Ops | -0.30 | -0.03 | 8.19 | -0.03 | -1.49 |
| EPS Diluted Discontinuous Ops | N/A | N/A | 0.85 | N/A | 0.29 |
| EPS Diluted Before Non-Recurring Items | N/A | -0.03 | N/A | -0.03 | -1.58 |
| EBITDA(a) | $-989 | $-1,027 | $-392 | $-991 | $-1,801 |